Association between surgeon characteristics and their preferences for guideline-concordant staging and treatment for rectal cancer - 05/11/14
, Lorren R. Mattingly-Wells, R.N., M.S.N. c, Jorge E. Marcet, M.D. d, Brenna C. McMahon Waldschmidt, M.S. a, John W. Cromwell, M.D. eAbstract |
Background |
Rectal cancer guidelines recommend transrectal ultrasound or magnetic resonance imaging for locoregional staging and neoadjuvant chemoradiation therapy (CRT) for Stage II/III disease, but studies show these are underutilized. We examined how surgeon preferences align with guidelines or vary by training.
Methods |
Questionnaires on training, years of practice, and staging/treatment preferences were sent to surgeons practicing in Florida.
Results |
Of 759 surveys distributed, 321 (42%) responded; 158 were excluded because they were trainees, not treating rectal cancer, or not board certified/eligible. Among the remaining 163, 71% were general surgeons, 18% colorectal surgeons, and 11% surgical oncologists. Colorectal surgeons and surgical oncologists were more likely than general surgeons to prefer transrectal ultrasound/magnetic resonance imaging (79% vs 50%; P < .01), and neoadjuvant CRT (71% vs 45%; P < .01). Differences remained significant after adjusting for years in practice.
Conclusion |
Increased focus on appropriate use of staging procedures and neoadjuvant CRT within general surgery training/educational programs is warranted.
Le texte complet de cet article est disponible en PDF.Keywords : Rectal cancer, Neoadjuvant therapy, Guideline adherence
Plan
| Disclaimers: This manuscript is not under review elsewhere and there is no prior publication of manuscript contents. The views expressed in this article are those of the authors and do not necessarily represent the views of the Department of Veterans Affairs. The authors report no conflict of interest in regards to this study. |
|
| There were no relevant financial relationships or any sources of support in the form of grants, equipment, or drugs. |
Vol 208 - N° 5
P. 817-823 - novembre 2014 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
